Understanding the genetic factors of Alzheimer's disease
Genetic Architecture of Alzheimer’s disease Proteinopathies
This study is looking at certain proteins in the brain to help us understand Alzheimer's disease better and figure out how it differs from other brain conditions, with the goal of finding ways to delay or prevent symptoms for people at risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10775757 on NIH RePORTER |
What this research studies
This research investigates the genetic architecture of Alzheimer's disease by focusing on specific biological markers that can be identified in living individuals. It aims to differentiate Alzheimer's from other brain disorders by using biomarkers such as amyloid-beta and pathologic tau. The study seeks to enhance our understanding of how these proteinopathies develop and to identify potential interventions that could delay or prevent the onset of Alzheimer's symptoms. By examining these genetic factors, the research hopes to provide a clearer picture of Alzheimer's disease progression and improve diagnostic capabilities.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for Alzheimer's disease, particularly those with a family history or genetic predisposition.
Not a fit: Patients with other types of dementia or neurodegenerative disorders that do not involve Alzheimer's-specific proteinopathies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses and targeted treatments for Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in using biomarkers to define Alzheimer's disease, indicating that this approach has potential for success.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Kamboh, M. Ilyas — University of Pittsburgh at Pittsburgh
- Study coordinator: Kamboh, M. Ilyas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.